Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction

2011 New England Journal of Medicine 859 citations

Abstract

The presence of viable myocardium was associated with a greater likelihood of survival in patients with coronary artery disease and left ventricular dysfunction, but this relationship was not significant after adjustment for other baseline variables. The assessment of myocardial viability did not identify patients with a differential survival benefit from CABG, as compared with medical therapy alone. (Funded by the National Heart, Lung, and Blood Institute; STICH ClinicalTrials.gov number, NCT00023595.).

Keywords

MedicineCardiologyHazard ratioInternal medicineCoronary artery diseaseDobutamineArteryConfidence intervalRandomized controlled trialHemodynamics

Affiliated Institutions

Related Publications

Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure

Abstract This article continues a series of reports on recent research developments in the field of heart failure. Key presentations made at the American College of Cardiology m...

2004 European Journal of Heart Failure 245 citations

Publication Info

Year
2011
Type
article
Volume
364
Issue
17
Pages
1617-1625
Citations
859
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

859
OpenAlex

Cite This

Robert O. Bonow, Gerald Maurer, Kerry L. Lee et al. (2011). Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction. New England Journal of Medicine , 364 (17) , 1617-1625. https://doi.org/10.1056/nejmoa1100358

Identifiers

DOI
10.1056/nejmoa1100358